Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial (OPTIMIZE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Medtronic
Information provided by:
Cardiovascular Research Center, Brazil
ClinicalTrials.gov Identifier:
NCT01113372
First received: April 22, 2010
Last updated: November 27, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
No publications provided by Cardiovascular Research Center, Brazil

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):